Skip to main content
logo
Lifecore Biomedical, Inc. (LFCR)
NASDAQ: LFCR · Real-Time Price · USD
6.40
-0.12 (-1.84%)
At close: Oct 30, 2026, 4:00 PM EDT
6.39
-0.01 (-0.16%)
After-hours: Oct 30, 2026, 7:30 PM EDT

Lifecore Biomedical Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2025FY 2024FY 2023FY 2022
Period Ending
Dec '25 May '25 May '24 May '23 May '22
Net Income
-30.79-38.7212.01-99.56-116.72
Depreciation & Amortization
9.58.037.9512.6817.66
Other Amortization
---0.50.4
Loss (Gain) From Sale of Assets
-7.780.02-2.070.15
Asset Writedown & Restructuring Costs
---0.645.19
Stock-Based Compensation
9.7210.166.23.612.61
Provision & Write-off of Bad Debts
---0.16-0.01
Other Operating Activities
29.4517.25-22.2324.53-7.25
Change in Accounts Receivable
2.76-5.17-2.3910.82-6.14
Change in Inventory
5.57.690.86-14.81-2.18
Change in Accounts Payable
-2.98-1.67-6.6816.049.34
Change in Unearned Revenue
---6.08-0.02
Change in Other Net Operating Assets
-10.59-5.544.511.66-4.11
Operating Cash Flow
12.57-0.210.26-17.44-22.59
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2025FY 2025FY 2024FY 2023FY 2022
Period Ending
Dec '25 May '25 May '24 May '23 May '22
Capital Expenditures
-6.34-13.42-18.4-21.48-29.94
Sale of Property, Plant & Equipment
17.147--1.14
Divestitures
---16.6773.5
Other Investing Activities
----35.26
Investing Cash Flow
10.81-6.42-18.4-4.8179.96

Financing Activities

Fiscal Year
FY 2025FY 2025FY 2024FY 2023FY 2022
Period Ending
Dec '25 May '25 May '24 May '23 May '22
Long-Term Debt Issued
-128.57149.59181.4575.11
Total Debt Issued
104.79128.57149.59181.4575.11
Long-Term Debt Repaid
--145.76-146.7-178.33-130.52
Total Debt Repaid
-109.07-145.76-146.7-178.33-130.52
Net Debt Issued (Repaid)
-4.29-17.192.883.12-55.41
Issuance of Common Stock
-23.85-4.82-
Repurchase of Common Stock
-1.94-1.27-0.15-0.27-0.79
Other Financing Activities
-1.371.044.78-6.05-0.82
Financing Cash Flow
-7.596.427.5139.7-57.02

Net Cash Flow

Fiscal Year
FY 2025FY 2025FY 2024FY 2023FY 2022
Period Ending
Dec '25 May '25 May '24 May '23 May '22
Net Cash Flow
15.78-0.2-10.6317.450.35

Free Cash Flow

Fiscal Year
FY 2025FY 2025FY 2024FY 2023FY 2022
Period Ending
Dec '25 May '25 May '24 May '23 May '22
Free Cash Flow
6.23-13.62-18.14-38.92-52.53
Free Cash Flow Growth
-----
Free Cash Flow Margin
4.81%-10.57%-14.14%-37.69%-47.21%
Free Cash Flow Per Share
0.17-0.39-0.49-1.30-1.78
Levered Free Cash Flow
--29.04-20.2716.29-26.82
Unlevered Free Cash Flow
--15.19-8.9327.28-17.15

Additional Metrics

Fiscal Year
FY 2025FY 2025FY 2024FY 2023FY 2022
Period Ending
Dec '25 May '25 May '24 May '23 May '22
Cash Interest Paid
2.521.912.7331.0216.89
Cash Income Tax Paid
-0.020.050.070.020.44
Change in Working Capital
-5.31-4.7-3.719.79-3.1
SEC Filings: 10-K · 10-Q